IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

Latest 10KSB40 SEC Filings
Annual Report Form for Small Businesses that also have a Positive Response to Item 405

BIOMUNE SYSTEMS INC, 10KSB40, 2001-01-16
SYNBIOTICS CORP, 10KSB40, 2000-04-13
EPOCH PHARMACEUTICALS INC, 10KSB40, 2000-03-30
HEMAGEN DIAGNOSTICS INC, 10KSB40, 1999-12-29
EPOCH PHARMACEUTICALS INC, 10KSB40, 1999-04-15
NUTRACEUTIX INC, 10KSB40, 1999-03-31
SYNBIOTICS CORP, 10KSB40, 1999-03-30
KAIRE HOLDINGS INC, 10KSB40, 1999-02-22
NORTH AMERICAN SCIENTIFIC INC, 10KSB40, 1999-01-21
EPOCH PHARMACEUTICALS INC, 10KSB40, 1998-04-15
SYNBIOTICS CORP, 10KSB40, 1998-04-14
BIO FLUORESCENT TECHNOLOGIES INC, 10KSB40, 1998-04-03
NORTH AMERICAN SCIENTIFIC INC, 10KSB40, 1998-01-29
VOLU SOL INC, 10KSB40, 1997-12-24
NEOPROBE CORP, 10KSB40, 1997-03-31
NORTH AMERICAN SCIENTIFIC INC, 10KSB40, 1997-01-21


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission